ANTX - An2 Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ANTX (1880438)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
27 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2024-11-19
ANTXReadnour Robin ShaneDirP - Purchase$1.07+200,000514,788+64%+$213,128
M
2024-11-18
ANTXZakrzewski Joseph SDirP - Purchase$1.00+25,000529,079+5%+$25,046
2024-11-18
ANTXEasom EricCEOP - Purchase$1.00+50,0001,361,012+4%+$49,970
2024-08-14
ANTXLeonard Braden Michael10%P - Purchase$1.04+1,500,0005,749,432+35%+$1,560,000
2024-08-09
ANTXRa Capital Management, L.P.10%S - Sale$1.08-3,525,094300,853-92%-$3,807,102
2024-01-18
ANTXZakrzewski Joseph SDirS - Sale$19.11-100,000504,079-17%-$1,911,410
2024-01-16
ANTXAziz KabeerDirS - Sale$19.65-100,0002,373,500-4%-$1,965,000
2024-01-16
ANTXAdjuvant Global Health Technology Fund, L.P.10%S - Sale$19.65-100,0002,373,500-4%-$1,965,000
2024-01-12
ANTXReadnour Robin ShaneDirS - Sale$21.92-1,425485,0730%-$31,229
2024-01-10
ANTXReadnour Robin ShaneDirS - Sale$21.93-3,669485,792-1%-$80,443
D
2024-01-09
ANTXKrause Kevin MichaelChief Strategy OfficerS - Sale+OE$20.14-7,4171,914-79%-$149,367
D
2024-01-02
ANTXKrause Kevin MichaelChief Strategy OfficerS - Sale+OE$20.12-2,5831,914-57%-$51,967
2024-01-02
ANTXEasom EricCEOS - Sale$20.09-2,7771,212,0120%-$55,802
2023-11-14
ANTXAdjuvant Global Health Technology Fund, L.P.10%S - Sale$16.15-1,8102,473,5000%-$29,224
2023-11-14
ANTXAziz KabeerDir, 10%S - Sale$16.15-1,8102,473,5000%-$29,224
M
2023-09-29
ANTXAziz KabeerDir, 10%S - Sale$16.27-104,7732,475,310-4%-$1,704,513
M
2023-09-29
ANTXAdjuvant Global Health Technology Fund, L.P.10%S - Sale$16.27-104,7732,475,310-4%-$1,704,513
M
2023-09-27
ANTXAdjuvant Global Health Technology Fund, L.P.10%S - Sale$16.11-9,3572,580,0830%-$150,708
M
2023-09-27
ANTXAziz KabeerDir, 10%S - Sale$16.11-9,3575,168,6820%-$150,708
2023-09-13
ANTXAziz KabeerDir, 10%S - Sale$16.00-4002,589,4400%-$6,400
2023-09-13
ANTXAdjuvant Global Health Technology Fund, L.P.10%S - Sale$16.00-4002,589,4400%-$6,400
M
2023-09-06
ANTXAdjuvant Global Health Technology Fund, L.P.10%S - Sale$16.03-7,1402,589,8400%-$114,484
M
2023-09-06
ANTXAziz KabeerDir, 10%S - Sale$16.03-7,1402,589,8400%-$114,484
2023-08-23
ANTXAdjuvant Global Health Technology Fund, L.P.10%S - Sale$16.00-4002,596,9800%-$6,400
2023-08-23
ANTXAziz KabeerDir, 10%S - Sale$16.00-4002,596,9800%-$6,400
2023-08-18
ANTXRa Capital Management, L.P.10%P - Purchase$9.00+1,777,7785,551,295+47%+$16,000,002
2023-05-15
ANTXEasom EricCEOP - Purchase$5.38+10,0001,214,789+1%+$53,770

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top